Facebook
Twitter
LinkedIn
ForwardUW Health 60th Pharmacy Reunion - August 4th, 2023
This continuing education activity is designed to provide participants market updates that are occurring for the 340B program. Participants will interact in a discussion, along with questions and answers from an industry expert to understand changing market dynamics from manufactures and legal decision, along with the developing strategies to support 340B program operations. Learners will also receive regulatory updates related to planned DSCSA requirements going into affect November 2023. Descriptions for proposed supply chain operations and potential technologies that can be deployed in a pharmacy to achieve regulatory requirements. Finally, learners will also receive UW Health Pharmacy program updates that have transpired over the past 24 months and opportunities for future program planning and expansion for the next 24 months.
Intended Audience
This program is intended for pharmacist leaders and clinicians.
Learning Objectives
Following this training the participant will be able to:
- Identify key changing market dynamics occurring for the 340B program.
- Outline three strategies to support 340B program operations based on the insights gained from the market updates and legal decisions presented.
- Describe specific actions, including DSCSA requirements, that a pharmacy can take to ensure compliance with the upcoming regulations effective from November 2023.
12:00 to 1:00 pm - Lunch
1:00 to 1:30 pm - 340B Program – Legal and Market Updates
1:30 to 2:30 pm - Drug Supple Chain and Security Act (DSCSA)
2:30 to 3:00 pm - UW Health Program Updates – the last 24 months and future strategy and technology use
3:00 PM - 4:00 PM - Tour of Central Pharmacy at University Hospital
4:00 PM - 5:00 PM - Optional tour Pharmacy Services Building (PSB)
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
| Name | Roles | Financial Relationship Disclosure | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
| Jack Temple, MS, PharmD, CPEL | Clinical Director/ Planning Committee Chair, Speaker | No relevant relationships with ineligible companies to disclose | No |
| Aliyah Cruz, PharmD | Planning Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Doug Lasch, PharmD | Planning Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
| Chris Hatwig, MS | Planning Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statement
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin–Madison ICEP designates this knowledge-based activity for a maximum of 2 hours or .2 CEUs. Credit can be earned by documented attendance, completing an evaluation, and participating in all sessions. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. Universal Activity Number (UAN): JA0000358-0000-23-049-L99-P
CONTINUING EDUCATION UNITS
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.2 continuing education units (CEUs) or 2 hours.
Available Credit
- 2.00 ACPE Contact Hours - Pharmacist
- 2.00 University of Wisconsin–Madison Continuing Education Hours